If you liked this article you might like

Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
Patient Deaths, Safety Concerns Cause Juno's CAR-T Pipeline to Skid Out
Jim Cramer's 'Mad Money' Recap: This Rotation's Too Hard for the Bulls
Bluebird, Celgene T-Cell Therapy Eliminates Multiple Myeloma With Minimal Side Effects